REFERENCE
1. Boersma LVA, Schmidt B, Betts TR, et al. Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry. Eur Heart J . 2016;37(31):2465-2474.
2. Holmes DR, Doshi SK, Kar S, et al. Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation: A Patient-Level Meta-Analysis. J Am Coll Cardiol . 2015;65(24):2614-2623.
3. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.Eur Heart J . 2016;37(38):2893-2962.
4. Gage BF, Yan Y, Milligan PE, et al. Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J . 2006;151(3):713-719.
5. Olesen JB, Lip GYH, Hansen ML, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: Nationwide cohort study. Bmj . 2011;342(7792):320.
6. Pisters R, Lane DA, Nieuwlaat R, et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The euro heart survey. Chest . 2010;138(5):1093-1100.
7. Landmesser U, Holmes DR. Left atrial appendage closure: A percutaneous transcatheter approach for stroke prevention in atrial fibrillation. Eur Heart J . 2012;33(6):698-704.
8. Alwi M, Leong MC. Catheter-Based Interventions on Intracardiac Shunts .; 2014.  1127-1151p
9. Della Rocca DG, Horton RP, Di Biase L, et al. First Experience of Transcatheter Leak Occlusion With Detachable Coils Following Left Atrial Appendage Closure. JACC Cardiovasc Interv . 2020;13(3):306-319.
10. Pillai AM, Kanmanthareddy A, Earnest M, et al. Initial experience with post Lariat left atrial appendage leak closure with Amplatzer septal occluder device and repeat Lariat application. Hear Rhythm . 2014;11(11):1877-1883.
11. Ewert P, Berger F, Nagdyman N, et al. Masked left ventricular restriction in elderly patients with atrial septal defects: A contraindication for closure? Catheter Cardiovasc Interv . 2001;52(2):177-180.
12. King RL, Cleveland FM. Interauricular septal defect with mitral stenosis; the Lutembacher syndrome. Bull Mason Clin . 1949;3(1):13-20.
13. Gutierrez C, Blanchard DG. Diastolic heart failure: Challenges of diagnosis and treatment. Am Fam Physician . 2004;69(11):2609-2616.
14. Abdelkarim A, Levi DS, Tran B, Ghobrial J, Aboulhosn J. Fenestrated Transcatheter ASD Closure in Adults with Diastolic Dysfunction and/or Pulmonary Hypertension: Case Series and Review of the Literature.Congenit Heart Dis . 2016;11(6):663-671.
15. Schneider HE, Jux C, Kriebel T, Paul T. Fate of a modified fenestration of atrial septal occluder device after transcatheter closure of atrial septal defects in elderly patients. J Interv Cardiol . 2011;24(5):485-490.
16. Akagi T. Current concept of transcatheter closure of atrial septal defect in adults. J Cardiol . 2015;65(1):17-25.
17. Kuwata S, Vierecke J, Gloekler S, Maisano F, Meier B, Nietlispach F. Left atrial appendage closure for “primary primary” prevention during percutaneous closure of septal defects in patients with large atria but no atrial fibrillation. Cardiol J . 2018;25(2):179-187.
18. Asmarats L, Cruz-González I, Nombela-Franco L, et al. Recurrence of Device-Related Thrombus after Percutaneous Left Atrial Appendage Closure. Circulation . 2019;140(17):1441-1443.
19. Dukkipati SR, Kar S, Holmes DR, et al. Device-related thrombus after left atrial appendage closure: Incidence, predictors, and outcomes.Circulation . 2018;138(9):874-885.